Araştırma Makalesi
BibTex RIS Kaynak Göster

Risk of Recurrence After Anti-Seizure Medication Discontinuation

Yıl 2024, Cilt: 11 Sayı: 2, 62 - 67, 31.08.2024
https://doi.org/10.47572/muskutd.1482913

Öz

With appropriate anti-seizure medication, long-term seizure freedom can be achieved in about 2/3 of patients with epilepsy. After long-term seizure freedom, the idea of medication discontinuation arises for both patients and physicians. In this study, we aimed to investigate seizure recurrence rates and the factors affecting recurrence in patients whose anti-seizure medication treatment was discontinued. Fifty patients were included in the study. Twenty-eight (56%) patients were female, with a mean age of 41.28±14.58 years and a mean duration of epilepsy of 15.20±9.90 years. Recurrence was observed in 14 (28%) patients. When the recurrence risk factors were analyzed, it was observed that the risk of recurrence decreased as the seizure-free period increased. Our study supports that the risk of relapse after discontinuation of anti-seizure medications decreases as the seizure-free period is prolonged. However, it should not be forgotten that the decision to discontinue medication should be individualized.

Etik Beyan

This study was approved by the human ethics committee of Antalya Training and Research Hospital. 25.04.2024 with protocol code 2024/072.

Destekleyen Kurum

No financial support was received from any institution, organization or person in our study.

Kaynakça

  • 1. Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279–86.
  • 2. Alsfouk BAA, Brodie MJ, Walters M, et al. Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy. JAMA Neurol. 2020;77(5):574–581.
  • 3. Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996; 47(2):600–2.
  • 4. Randomised study of antiepileptic drug withdrawal in patients in remission. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Lancet. 1991;337(8751):1175-80.
  • 5. Camfield P, Camfield C. When is it safe to discontinue AED treatment?. Epilepsia 2008;49(Suppl 9):25–8.
  • 6. Beghi E, Giussani G, Grosso S, et al. Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy. Epilepsia. 2013;54(suppl 7):2-12.
  • 7. Gloss D, Pargeon K, Pack A, et al. Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary. Neurology. 2021;97(23):1072-81.
  • 8. Mesraoua B, Perucca E, Tomson T, et al. Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy?. Epilepsy Behav. 2023;142:109205.
  • 9. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.
  • 10. Li Y, Chen S, Qin J, et al. Risk of seizure recurrence from antiepileptic drug withdrawal among seizure-free patients for more than two years. Epilepsy Behav. 2020;113:107485.
  • 11. Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist. 2009;15(3):122–31.
  • 12. Balçık ZE, Şenadım E, Söylemez E, et al. Antiepileptik İlaçların Kesilmesi Güvenli midir? Epilepsi: J Turkish Epil Soc. 2020;26(1):35-39.
  • 13. Vurucu S, Saldir M, Unay B, et al. Determination of risk factors associated with seizure relapse after antiepileptic drug withdrawal. Cent Eur J Med. 2010;5:251–6.
  • 14. Pavlović M, Jović N, Pekmezović T. Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy. Seizure. 2011;20(7):520-5.
  • 15. Ou S, Xia L, Li R, et al. Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal. Epilepsy Behav. 2018;88:295-300.
  • 16. Shinnar S, Berg AT, Moshé SL, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol. 1994;35(5):534-45.
  • 17. Bouma PA, Peters AC, Brouwer OF. Long term course of childhood epilepsy following relapse after antiepileptic drug withdrawal. J Neurol Neurosurg Psychiatry. 2002;72(4):507-10.
  • 18. Rizvi S, Ladino LD, Hernandez-Ronquillo L, et al. Epidemiology of early stages of epilepsy: Risk of seizure recurrence after a first seizure. Seizure. 2017;49:46-53.
  • 19. Tang L, Xiao Z. Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: A meta-analysis. Clin Neurophysiol. 2017;128(2):297-302.
  • 20. Afshari D, Moradian N. Evaluating the rate of recurrence of epilepsy after therapy discontinuation in 2-year seizure-free epileptic patients. Int J Neurosci. 2012;122(10):598-601.
  • 21. Cardoso TA, Coan AC, Kobayashi E, et al. Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology. 2006;67(1):134-6.
  • 22. Ramos-Lizana J, Aguirre-Rodríguez J, Aguilera-López P, et al. Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: a prospective study. Eur J Paediatr Neurol. 2010;14(2):116-24.
  • 23. Benbadis SR, Beniczky S, Bertram E, et al. The role of EEG in patients with suspected epilepsy. Epileptic Disord. 2020;22(2):143-55.
  • 24. Overweg J, Binnie CD, Oosting J, et al. Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal. Epilepsy Res. 1987;1(5):272-83.
  • 25. Matricardi A, Bertamino F, Risso D. Discontinuation of anti-epileptic therapy: a retrospective study of 86 children and adolescents. Ital J Neurol Sci. 1995;16(9):613-22.
  • 26. Schmidt D, Sillanpää M. Stopping epilepsy treatment in seizure remission: Good or bad or both?. Seizure. 2017;44:157-61.
  • 27. Chadwick D, Taylor J, Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC antiepileptic drug withdrawal group. Epilepsia. 1996;37(11):1043-50.
  • 28. Cho J, Kim H, Chae J, et al. Outcomes of the second withdrawal of anti‐seizure medication in patients with pediatric‐onset epilepsy. Epilepsia, 2023;64(6):e93-7.
  • 29. Lossius MI, Alfstad KÅ, Aaberg KM, et al. Discontinuation of antiepileptic drugs in seizure-free patients - when and how?. 2017;137(6):451-4.

Nöbet Önleyici İlaç kesimi Sonrası Rekürrens Riski

Yıl 2024, Cilt: 11 Sayı: 2, 62 - 67, 31.08.2024
https://doi.org/10.47572/muskutd.1482913

Öz

Uygun nöbet önleyici ilaç tedavisi ile epilepsi hastalarının yaklaşık 2/3'ünde nöbetsizlik sağlanabilmektedir. Uzun süreli nöbetsizlikten sonra hem hastalar hem de hekimler için ilaçların kesilmesi fikri ön plana çıkmaktadır. Biz de bu çalışma ile nöbet önleyici ilaç tedavisi kesilen hastalarda nöbet nüks oranlarını ve nüksü etkileyen faktörleri araştırmayı amaçladık. Çalışmaya 50 hasta dahil edildi. Hastaların 28'i (%56) kadındı, yaş ortalaması 41.28±14.58 yıl ve ortalama epilepsi süresi 15.20±9.90 yıldı. Hastaların 14'ünde (%28) nüks gözlendi. Nüks risk faktörleri incelendiğinde, nöbetsizlik süresi arttıkça nüks riskinin azaldığı tespit edildi. Çalışmamız nöbet önleyici ilaçların kesilmesinden sonra nüks riskinin ilaç kesim öncesi nöbetsizlik süresi uzadıkça azaldığını desteklemektedir. Ancak, ilacı bırakma kararının hasta bazında bireyselleştirilmesi gerektiği unutulmamalıdır.

Kaynakça

  • 1. Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279–86.
  • 2. Alsfouk BAA, Brodie MJ, Walters M, et al. Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy. JAMA Neurol. 2020;77(5):574–581.
  • 3. Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996; 47(2):600–2.
  • 4. Randomised study of antiepileptic drug withdrawal in patients in remission. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Lancet. 1991;337(8751):1175-80.
  • 5. Camfield P, Camfield C. When is it safe to discontinue AED treatment?. Epilepsia 2008;49(Suppl 9):25–8.
  • 6. Beghi E, Giussani G, Grosso S, et al. Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy. Epilepsia. 2013;54(suppl 7):2-12.
  • 7. Gloss D, Pargeon K, Pack A, et al. Antiseizure medication withdrawal in seizure-free patients: practice advisory update summary. Neurology. 2021;97(23):1072-81.
  • 8. Mesraoua B, Perucca E, Tomson T, et al. Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy?. Epilepsy Behav. 2023;142:109205.
  • 9. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-82.
  • 10. Li Y, Chen S, Qin J, et al. Risk of seizure recurrence from antiepileptic drug withdrawal among seizure-free patients for more than two years. Epilepsy Behav. 2020;113:107485.
  • 11. Shih JJ, Ochoa JG. A systematic review of antiepileptic drug initiation and withdrawal. Neurologist. 2009;15(3):122–31.
  • 12. Balçık ZE, Şenadım E, Söylemez E, et al. Antiepileptik İlaçların Kesilmesi Güvenli midir? Epilepsi: J Turkish Epil Soc. 2020;26(1):35-39.
  • 13. Vurucu S, Saldir M, Unay B, et al. Determination of risk factors associated with seizure relapse after antiepileptic drug withdrawal. Cent Eur J Med. 2010;5:251–6.
  • 14. Pavlović M, Jović N, Pekmezović T. Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy. Seizure. 2011;20(7):520-5.
  • 15. Ou S, Xia L, Li R, et al. Long-term outcome of seizure-free patients and risk factors of relapse following antiepileptic drug withdrawal. Epilepsy Behav. 2018;88:295-300.
  • 16. Shinnar S, Berg AT, Moshé SL, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol. 1994;35(5):534-45.
  • 17. Bouma PA, Peters AC, Brouwer OF. Long term course of childhood epilepsy following relapse after antiepileptic drug withdrawal. J Neurol Neurosurg Psychiatry. 2002;72(4):507-10.
  • 18. Rizvi S, Ladino LD, Hernandez-Ronquillo L, et al. Epidemiology of early stages of epilepsy: Risk of seizure recurrence after a first seizure. Seizure. 2017;49:46-53.
  • 19. Tang L, Xiao Z. Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: A meta-analysis. Clin Neurophysiol. 2017;128(2):297-302.
  • 20. Afshari D, Moradian N. Evaluating the rate of recurrence of epilepsy after therapy discontinuation in 2-year seizure-free epileptic patients. Int J Neurosci. 2012;122(10):598-601.
  • 21. Cardoso TA, Coan AC, Kobayashi E, et al. Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology. 2006;67(1):134-6.
  • 22. Ramos-Lizana J, Aguirre-Rodríguez J, Aguilera-López P, et al. Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: a prospective study. Eur J Paediatr Neurol. 2010;14(2):116-24.
  • 23. Benbadis SR, Beniczky S, Bertram E, et al. The role of EEG in patients with suspected epilepsy. Epileptic Disord. 2020;22(2):143-55.
  • 24. Overweg J, Binnie CD, Oosting J, et al. Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal. Epilepsy Res. 1987;1(5):272-83.
  • 25. Matricardi A, Bertamino F, Risso D. Discontinuation of anti-epileptic therapy: a retrospective study of 86 children and adolescents. Ital J Neurol Sci. 1995;16(9):613-22.
  • 26. Schmidt D, Sillanpää M. Stopping epilepsy treatment in seizure remission: Good or bad or both?. Seizure. 2017;44:157-61.
  • 27. Chadwick D, Taylor J, Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC antiepileptic drug withdrawal group. Epilepsia. 1996;37(11):1043-50.
  • 28. Cho J, Kim H, Chae J, et al. Outcomes of the second withdrawal of anti‐seizure medication in patients with pediatric‐onset epilepsy. Epilepsia, 2023;64(6):e93-7.
  • 29. Lossius MI, Alfstad KÅ, Aaberg KM, et al. Discontinuation of antiepileptic drugs in seizure-free patients - when and how?. 2017;137(6):451-4.
Toplam 29 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri (Diğer)
Bölüm Araştırma Makalesi
Yazarlar

Firdevs Ezgi Uçan Tokuç 0000-0002-0347-6026

Merve Gürsoy Hasoğlan 0000-0002-4035-4757

Fatma Genç 0000-0002-6062-3694

Meltem Korucuk 0000-0002-0497-3980

Abidin Erdal 0000-0003-3698-8201

Yasemin Biçer Gömceli 0000-0001-5043-0891

Yayımlanma Tarihi 31 Ağustos 2024
Gönderilme Tarihi 13 Mayıs 2024
Kabul Tarihi 31 Temmuz 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 11 Sayı: 2

Kaynak Göster

APA Uçan Tokuç, F. E., Gürsoy Hasoğlan, M., Genç, F., Korucuk, M., vd. (2024). Risk of Recurrence After Anti-Seizure Medication Discontinuation. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 11(2), 62-67. https://doi.org/10.47572/muskutd.1482913
AMA Uçan Tokuç FE, Gürsoy Hasoğlan M, Genç F, Korucuk M, Erdal A, Biçer Gömceli Y. Risk of Recurrence After Anti-Seizure Medication Discontinuation. MMJ. Ağustos 2024;11(2):62-67. doi:10.47572/muskutd.1482913
Chicago Uçan Tokuç, Firdevs Ezgi, Merve Gürsoy Hasoğlan, Fatma Genç, Meltem Korucuk, Abidin Erdal, ve Yasemin Biçer Gömceli. “Risk of Recurrence After Anti-Seizure Medication Discontinuation”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 11, sy. 2 (Ağustos 2024): 62-67. https://doi.org/10.47572/muskutd.1482913.
EndNote Uçan Tokuç FE, Gürsoy Hasoğlan M, Genç F, Korucuk M, Erdal A, Biçer Gömceli Y (01 Ağustos 2024) Risk of Recurrence After Anti-Seizure Medication Discontinuation. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 11 2 62–67.
IEEE F. E. Uçan Tokuç, M. Gürsoy Hasoğlan, F. Genç, M. Korucuk, A. Erdal, ve Y. Biçer Gömceli, “Risk of Recurrence After Anti-Seizure Medication Discontinuation”, MMJ, c. 11, sy. 2, ss. 62–67, 2024, doi: 10.47572/muskutd.1482913.
ISNAD Uçan Tokuç, Firdevs Ezgi vd. “Risk of Recurrence After Anti-Seizure Medication Discontinuation”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 11/2 (Ağustos 2024), 62-67. https://doi.org/10.47572/muskutd.1482913.
JAMA Uçan Tokuç FE, Gürsoy Hasoğlan M, Genç F, Korucuk M, Erdal A, Biçer Gömceli Y. Risk of Recurrence After Anti-Seizure Medication Discontinuation. MMJ. 2024;11:62–67.
MLA Uçan Tokuç, Firdevs Ezgi vd. “Risk of Recurrence After Anti-Seizure Medication Discontinuation”. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, c. 11, sy. 2, 2024, ss. 62-67, doi:10.47572/muskutd.1482913.
Vancouver Uçan Tokuç FE, Gürsoy Hasoğlan M, Genç F, Korucuk M, Erdal A, Biçer Gömceli Y. Risk of Recurrence After Anti-Seizure Medication Discontinuation. MMJ. 2024;11(2):62-7.